Halo Pharma News and Resources

The Noramco Group has announced a $25 million investment in its Halo Pharma facility in Whippany, New Jersey, to establish sterile injectable manufacturing capabilities. The expansion will include ready-to-use syringe, cartridge, and vial filling, addressing critical capacity shortages in the U.S. injectable supply chain.